Advertisement
Canada markets open in 7 hours 35 minutes
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7330
    +0.0007 (+0.10%)
     
  • CRUDE OIL

    83.96
    +0.39 (+0.47%)
     
  • Bitcoin CAD

    88,059.64
    +363.75 (+0.41%)
     
  • CMC Crypto 200

    1,388.82
    +6.24 (+0.45%)
     
  • GOLD FUTURES

    2,347.20
    +4.70 (+0.20%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    -4.6520 (-49.71%)
     
  • NASDAQ futures

    17,766.50
    +199.00 (+1.13%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,980.48
    +352.00 (+0.94%)
     
  • CAD/EUR

    0.6829
    +0.0008 (+0.12%)
     

KCSA Psychedelics Virtual Investor Conference Agenda Announced for April 27th & 28th

Virtual Investor Conferences
Virtual Investor Conferences

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with KCSA Strategic Communications (“KCSA”), today announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Conference to be held on April 27-28, 2022. Individual investors, institutional investors, advisors, and analysts are invited to attend this two-day virtual event showcasing live company presentations and interactive discussions focused on psychedelic treatments for mental health disorders.

“As we have seen over the past 18 months, drug development is hard. The good news is many of the companies presenting over the two-day event have shown tremendous clinical progress. I would encourage investors to take a traditional pharma or biotech view of this space and practice patience, do the proper diligence, and the rewards will be tremendous,” said Lewis Goldberg, Managing Partner and Founder of KCSA’s Psychedelics Practice. “Drug development for mental health care takes time, focus, and is capital intensive. The potential returns remain as dramatic as ever, it’s the investors who – to steal a line from Michael Pollan – need to change their minds.”

ADVERTISEMENT

REGISTER NOW AT: https://bit.ly/3rFbSuZ

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations and schedule 1x1 meetings.

April 27th Agenda:

Eastern
Time (ET)

Presentation

Ticker(s)

9:30 AM

HMNC Brain Health

Private

10:00 AM

Field Trip Health Ltd.

NASDAQ: FTRP | TSX: FTRP

10:30 AM

Psyched Wellness Ltd.

OTCQB: PSYCF | CSE: PSYC

11:00 AM

Enveric Biosciences

NASDAQ: ENVB

11:30 AM

Lobe Sciences Ltd.

OTCQB: LOBEF | CSE: LOBE

12:00 PM

Ninnion Therapeutics

Private

12:30 PM

PsyBio Therapeutics

OTCQB: PSYBF | TSXV: PSYB

1:00 PM

Numinus Wellness

OTCQX: NUMIF | TSX: NUMI

April 28th Agenda:

Eastern
Time (ET)

Presentation

Ticker(s)

9:30 AM

Small Pharma Inc.

OTCQB: DMTTF | TSXV: DMT

10:00 AM

Mindset Pharma Inc.

OTCQB: MSSTF | CSE: MSET

10:30 AM

Gilgamesh Pharma

Private

11:00 AM

Cybin Inc.

NYSE AMEX: CYBN | NEO: CYBN

11:30 AM

Filament Health Corp.

OTCQB: FLHLF | NEO: FH

12:00 PM

Awaken Life Sciences Corp.

OTCQB: AWKNF | NEO: AWKN

To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.

About Virtual Investor Conferences®

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

About KCSA Strategic Communications

KCSA is a fully integrated communications agency specializing in public relations, investor relations and social media, with expertise in financial and professional services, technology, healthcare, digital media and cannabis. Since 1969, the firm has demonstrated strategic thinking and program execution that drives results for its clients in the ever-changing communications and digital landscape. The firm's clients are its best references. For more information, please visit www.kcsa.com.

Media Contact:
OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com

Virtual Investor Conferences Contact:
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com

KCSA Contact:
Allison Soss / Tim Regan
KCSA Strategic Communications
conference@kcsa.com